148 related articles for article (PubMed ID: 8334678)
1. The potential for proteinase inhibition in cancer treatment.
Dodwell DJ; Howell A
Cancer Treat Rev; 1993 Jul; 19(3):283-96. PubMed ID: 8334678
[No Abstract] [Full Text] [Related]
2. Extracellular proteases as targets for treatment of cancer metastases.
Lee M; Fridman R; Mobashery S
Chem Soc Rev; 2004 Sep; 33(7):401-9. PubMed ID: 15354221
[TBL] [Abstract][Full Text] [Related]
3. Proteinase inhibition in invasive cancer therapy: four control levels of matrix degradation.
Opdenakker G; Paemen L; Norga K; Masure S
Int J Cancer; 1997 Mar; 70(5):628-30. PubMed ID: 9052766
[No Abstract] [Full Text] [Related]
4. Matrix-degrading proteases in hormone-dependent breast cancer.
Dickson RB; Shi YE; Johnson MD
Breast Cancer Res Treat; 1994; 31(2-3):167-73. PubMed ID: 7881096
[TBL] [Abstract][Full Text] [Related]
5. [Extracellular matrix degradative enzymes and neoplasm invasiveness and metastasis].
Wang F; Gao J
Zhonghua Bing Li Xue Za Zhi; 1992 Apr; 21(2):121-3. PubMed ID: 1499073
[No Abstract] [Full Text] [Related]
6. Protease inhibitors: role and potential therapeutic use in human cancer.
DeClerck YA; Imren S
Eur J Cancer; 1994; 30A(14):2170-80. PubMed ID: 7857719
[TBL] [Abstract][Full Text] [Related]
7. [Antiproteases in the pathogenesis of neoplastic diseases].
Dabrowska M
Przegl Lek; 1998; 55(9):475-9. PubMed ID: 10085727
[TBL] [Abstract][Full Text] [Related]
8. [Proteases in malignant tumors. Their significance for pathogenesis and possible therapeutic consequences].
Fröhlich E
Dtsch Med Wochenschr; 2004 Feb; 129(8):391-5. PubMed ID: 14961448
[No Abstract] [Full Text] [Related]
9. Proteases and protease inhibitors in cancer.
Van Noorden CJ
Acta Histochem; 1998 Nov; 100(4):344-54. PubMed ID: 9842415
[TBL] [Abstract][Full Text] [Related]
10. Estrogen regulated proteases and antiproteases in ovarian and breast cancer cells.
Rochefort H; Chalbos D; Cunat S; Lucas A; Platet N; Garcia M
J Steroid Biochem Mol Biol; 2001; 76(1-5):119-24. PubMed ID: 11384869
[TBL] [Abstract][Full Text] [Related]
11. Are proteinase inhibitors potentially useful in tumor therapy?
Nelles LP; Schnebli HP
Invasion Metastasis; 1982; 2(2):113-24. PubMed ID: 6203867
[TBL] [Abstract][Full Text] [Related]
12. [Metalloproteinases in tumor progression. Review].
Arvelo F; Cotte C
Invest Clin; 2006 Jun; 47(2):185-205. PubMed ID: 16886780
[TBL] [Abstract][Full Text] [Related]
13. Membrane proteases as potential diagnostic and therapeutic targets for breast malignancy.
Chen WT; Lee CC; Goldstein L; Bernier S; Liu CH; Lin CY; Yeh Y; Monsky WL; Kelly T; Dai M
Breast Cancer Res Treat; 1994; 31(2-3):217-26. PubMed ID: 7881100
[TBL] [Abstract][Full Text] [Related]
14. [The role of proteolytic enzymes and their inhibitors in malignant neoplasm invasion (literature review)].
Oglovlina OG; Aref'eva TI
Biokhimiia; 1994 Mar; 59(3):340-52. PubMed ID: 8180267
[TBL] [Abstract][Full Text] [Related]
15. Imaging metalloproteinase activity in vivo.
Zucker S; Cao J
Nat Med; 2001 Jun; 7(6):655-6. PubMed ID: 11385494
[No Abstract] [Full Text] [Related]
16. Modified proenzymes as artificial substrates for proteolytic enzymes: colorimetric assay of bacterial collagenase and matrix metalloproteinase activity using modified pro-urokinase.
Verheijen JH; Nieuwenbroek NM; Beekman B; Hanemaaijer R; Verspaget HW; Ronday HK; Bakker AH
Biochem J; 1997 May; 323 ( Pt 3)(Pt 3):603-9. PubMed ID: 9169591
[TBL] [Abstract][Full Text] [Related]
17. GSIs described as most important finding in cancer-targeting research.
Expert Rev Anticancer Ther; 2002 Dec; 2(6):617-8. PubMed ID: 12503199
[No Abstract] [Full Text] [Related]
18. ADAM8 in invasive cancers: links to tumor progression, metastasis, and chemoresistance.
Conrad C; Benzel J; Dorzweiler K; Cook L; Schlomann U; Zarbock A; Slater EP; Nimsky C; Bartsch JW
Clin Sci (Lond); 2019 Jan; 133(1):83-99. PubMed ID: 30635388
[TBL] [Abstract][Full Text] [Related]
19. Proteases and protease inhibitors in tumor progression.
DeClerck YA; Imren S; Montgomery AM; Mueller BM; Reisfeld RA; Laug WE
Adv Exp Med Biol; 1997; 425():89-97. PubMed ID: 9433492
[TBL] [Abstract][Full Text] [Related]
20. Biologists take degrading route to tackle cancer.
Abbott A
Nature; 2004 Jun; 429(6994):794. PubMed ID: 15215827
[No Abstract] [Full Text] [Related]
[Next] [New Search]
